BiomimX is a pioneer in Organ on a Chip (OoC) technology, producing the next generation of clinically relevant in-vitro models for pharmaceutical drug discovery and testing. Its proprietary platform, uBeat®, integrates microfluidics, 3D cell culture, live human cells, and mechanical stimuli to produce « Beating Organs on Chip ». These recapitulate, with unprecedented precision and predictability, clinically relevant models reflective of human patho-physiology, amenable for drug safety and efficacy testing. A key highlight is uHeart, BiomimX leading platform validated for predicting cardiotoxicity. In addition to uHeart, BiomimX has developed 3 validated models (cardio-fibrosis, gut, and knee) and is actively working on liver and lung models, all of which replicate human physiology and patho-physiology with unprecedented precision. To know more
